David Fuentes, MD | |
109 Falls Ct, Ste 100, Boerne, TX 78006-2978 | |
(830) 249-0633 | |
(830) 249-0622 |
Full Name | David Fuentes |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 33 Years |
Location | 109 Falls Ct, Boerne, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013911544 | NPI | - | NPPES |
042756902 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | J3309 (Texas) | Primary |
Entity Name | David Fuentes Md Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265611420 PECOS PAC ID: 9133186513 Enrollment ID: O20041216001063 |
News Archive
Lisa Hartling, co-director for the University of Alberta's Alberta Research Centre for Health Evidence, looked at 163 North American clinical trials involving children by using a new tool that rates the risk of bias, meaning the benefits and safety of the treatments may have been exaggerated.
John Michael Criley, MD, a Los Angeles Biomedical Research Institute researcher, will receive the 2016 Distinguished Teacher Award from the American College of Cardiology on April 4 at the organization's 65th Annual Scientific Session in Chicago, IL.
Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.
Congressional Republicans are releasing two health care reform proposals - one from conservatives and one from moderates - as alternatives to plans by Democrats, CQ Today reports (Wayne, CQ Today, 5/19).
The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
David Fuentes, MD 109 Falls Ct, Ste 100, Boerne, TX 78006-2977 Ph: (830) 249-0633 | David Fuentes, MD 109 Falls Ct, Ste 100, Boerne, TX 78006-2978 Ph: (830) 249-0633 |
News Archive
Lisa Hartling, co-director for the University of Alberta's Alberta Research Centre for Health Evidence, looked at 163 North American clinical trials involving children by using a new tool that rates the risk of bias, meaning the benefits and safety of the treatments may have been exaggerated.
John Michael Criley, MD, a Los Angeles Biomedical Research Institute researcher, will receive the 2016 Distinguished Teacher Award from the American College of Cardiology on April 4 at the organization's 65th Annual Scientific Session in Chicago, IL.
Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.
Congressional Republicans are releasing two health care reform proposals - one from conservatives and one from moderates - as alternatives to plans by Democrats, CQ Today reports (Wayne, CQ Today, 5/19).
The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.
› Verified 2 days ago